Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.

S'inscrire

SCNI Scinai Immunotherapeutics Ltd

2,98

0,04 (1,36%)

03 Juil 2024 - Fermé

Retardé de 15 minutes

Biotech Rips Following Five-Year Master Service Agreement Release

There is something about biotech companies that seems to get everyone excited in the penny stock realm. Whether it’s the potential for major FDA approval announcements or...

To read the full story on AllPennyStocks.com, click here.

Scinai Immunotherapeutics (NASDAQ:SCNI)
Graphique Historique de l'Action
De Juin 2024 à Juil 2024

Plus de graphiques de la Bourse Scinai Immunotherapeutics

Scinai Immunotherapeutics (NASDAQ:SCNI)
Graphique Historique de l'Action
De Juil 2023 à Juil 2024

Plus de graphiques de la Bourse Scinai Immunotherapeutics

Actualités Scinai Immunotherapeutics Ltd

Scinai Publishes Q1 2024 Financial Results and Provides Business Update
Mardi 2 Juillet 2024 ( il y a 14 heures) • PR Newswire (US)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Vendredi 14 Juin 2024 ( il y a 3 semaines) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Jeudi 13 Juin 2024 ( il y a 3 semaines) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Jeudi 13 Juin 2024 ( il y a 3 semaines) • Edgar (US Regulatory)

Scinai Immunotherapeutics Announces Receipt of a Letter of Intent from the European Investment Bank Providing Specific Terms for Conversion of its Loan to Equity.
Jeudi 13 Juin 2024 ( il y a 3 semaines) • PR Newswire (US)

Scinai Immunotherapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement; Continues to Work with the European Investment Bank to Convert Loan to Equity to Regain Compliance with Nasdaq Minimum Shareholders' Equity Requirement
Vendredi 7 Juin 2024 ( il y a 4 semaines) • PR Newswire (US)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Mardi 28 Mai 2024 ( il y a 1 mois) • Edgar (US Regulatory)

Scinai Immunotherapeutics Announces Receipt of a Nasdaq Staff Determination Letter Regarding Shareholders' Equity listing requirements and Hearing to Present a Plan for Regaining Compliance
Vendredi 24 Mai 2024 ( il y a 1 mois) • PR Newswire (US)

Form 424B3 - Prospectus [Rule 424(b)(3)]
Jeudi 16 Mai 2024 ( il y a 2 mois) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Mercredi 15 Mai 2024 ( il y a 2 mois) • Edgar (US Regulatory)

Scinai Publishes FY 2023 Financial Statements, Files Annual Report on Form 20-F and Provides Business Update
Mercredi 15 Mai 2024 ( il y a 2 mois) • PR Newswire (US)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Mardi 7 Mai 2024 ( il y a 2 mois) • Edgar (US Regulatory)

Plus d'articles sur Scinai Immunotherapeutics Ltd

Cie de SaintGobain

Credit Agricole

JP Morgan Chase

Delayed Upgrade Clock

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales